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Abstract
 
Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) are used by several human
pathogens to anchor themselves to or invade host cells. Interestingly, human granulocytes express
a specific isoform, CEACAM3, that participates together with CEACAM1 and CEACAM6 in
the recognition of CEACAM-binding microorganisms. Here we show that CEACAM3 can
direct efficient, opsonin-independent phagocytosis of CEACAM-binding 
 
Neisseria
 
, 
 
Moraxella
 
,
and 
 
Haemophilus
 
 species. CEACAM3- but not CEACAM6-mediated uptake is blocked by
dominant-negative versions of the small GTPase Rac. Moreover, CEACAM3 engagement
triggers membrane recruitment and increased GTP loading of Rac that are not observed upon
bacterial binding to CEACAM6. Internalization and Rac stimulation are also inhibited by com-
promising the integrity of an immunoreceptor tyrosine-based activation motif (ITAM)–like
sequence in the cytoplasmic tail of CEACAM3 or by interference with Src family protein tyro-
sine kinases that phosphorylate CEACAM3. In contrast to interfering with CEACAM6, blockage
of CEACAM3-mediated events reduces the ability of primary human granulocytes to internalize
and eliminate CEACAM-binding bacteria, indicating an important role of CEACAM3 in the
control of human-specific pathogens by the innate immune system.
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Introduction
 
The gram-negative pathogens 
 
Neisseria gonorrhoeae
 
, 
 
N.
meningitidis
 
, 
 
Moraxella catarrhalis
 
, and 
 
Haemophilus influenzae
 
are highly adapted to the human as their sole natural host.
They colonize mucosal surfaces in different parts of the
body: the nasopharynx in the case of 
 
N. meningitidis
 
, 
 
M.
catarrhalis
 
, and 
 
H. influenzae 
 
or the urogenital tract in the
case of 
 
N. gonorrhoeae
 
. Though colonization with these
pathogens can develop into invasive and sometimes life-
threatening diseases, colonization most often (
 
N. meningitidis
 
,
 
M. catarrhalis
 
, and 
 
H. influenzae
 
) or in a large proportion of
the cases (
 
N. gonorrhoeae
 
) remains without symptoms (1). In
particular, in gonorrhea the often mild symptoms can resolve
despite the lack of effective acquired immunity (1–3),
suggesting that innate immune defenses are able to contain
the pathogen.
The four pathogenic species share several common adap-
tations such as phase or antigenic variation of surface struc-
tures and expression of outer membrane proteins that mediate
the binding to members of the carcinoembryonic antigen-
related cell adhesion molecule (CEACAM) family on human
cells (4–8). In the case of 
 
H. influenzae
 
, CEACAM recognition
is mediated by the P5 protein found on typeable and non-
typeable strains (9), whereas UspA1 has been identified
recently as the 
 
M. catarrhalis
 
 CEACAM-binding protein (7).
CEACAM recognition by pathogenic 
 
Neisseriae
 
 is mediated
by members of the phase-variable Opa protein family
(Opa
 
CEA
 
) (for review see reference 10).
Opa
 
CEA
 
 proteins from gonococci and meningococci can
recognize four members of the human CEACAM family,
namely CEACAM1, CEACAM3, CEA, and CEACAM6
(6, 11, 12). The complete spectra of CEACAMs recog-
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nized by the P5 protein of 
 
H. influenzae
 
 or the UspA1 pro-
tein of 
 
M. catarrhalis
 
 have not been analyzed in detail, but
they seem to overlap the spectrum of Opa
 
CEA
 
-recognized
CEACAMs (7, 8). Except for CEACAM1, homologues of
these human receptors have not been detected in rodents,
limiting the in vivo analysis of CEACAM function.
In vitro experiments suggest that several CEACAMs
contribute to cell–cell adhesion by homo- or heterotypic
interaction and participate in signal transduction into the
cell (13). With regard to pathogen-induced signaling
events, Opa
 
CEA
 
-mediated engagement of CEACAM1 ex-
pressed on activated CD4-positive T cells has been shown
to cause an arrest of T cell proliferation in vitro (14). This
immunosuppressive effect is presumably due to negative
signals emanating from a functional immunoreceptor tyro-
sine-based inhibitory motif in the cytoplasmic tail of
CEACAM1 (15). CEACAM1 together with CEACAM3
and CEACAM6 is expressed on granulocytes that internal-
ize CEACAM-binding bacteria in the absence of opsoniz-
ing antibodies or complement factors (4, 5, 16, 17). This
opsonin-independent phagocytosis is accompanied by in-
creased activity of Src family protein tyrosine kinases
(PTKs), stimulation of the small GTPase Rac, and promi-
nent rearrangements of the actin cytoskeleton (17, 18), sug-
gesting that human phagocytes can specifically detect and
efficiently internalize bacteria that express CEACAM-
binding adhesins. However, it is so far unclear which of the
different CEACAM receptors expressed on granulocytes is
responsible for the signaling events observed in response to
CEACAM-binding pathogens and if these biochemical
events are linked to the elimination of CEACAM-binding
bacteria by human phagocytes.
In this study, we demonstrate that the granulocyte-spe-
cific orphan receptor CEACAM3 is linked to the stimula-
tion of the small GTPase Rac in response to pathogenic,
CEACAM-binding 
 
N. gonorrhoeae
 
, 
 
M. catarrhalis
 
, and 
 
H. in-
fluenzae
 
. Stimulation of Rac is dependent on Src family
kinase–mediated phosphorylation of the ITAM-like se-
quence in the cytoplasmic domain of CEACAM3 and leads
to the efficient internalization of the pathogens. Since
blockage of CEACAM3 or interference with Rac stimula-
tion reduce phagocyte clearance of CEACAM-binding
bacteria, our results suggest an important function for
CEACAM3 in the control of human-specific pathogens by
the innate immune system.
 
Materials and Methods
 
Bacteria.
 
Opa
 
CEA
 
-expressing (Opa
 
52
 
), nonpiliated 
 
N. gonor-
rhoeae
 
 MS11-B2.1 (strain N309), nonopaque, piliated gonococci
MS11, and commensal 
 
N. cinerea
 
 were provided by Thomas
Meyer (Max-Planck-Institut für Infektionsbiologie, Berlin, Ger-
many). 
 
Neisseria
 
 were grown on GC-agar (GIBCO BRL) supple-
mented with vitamins at 37
 
 
 
C, 5% CO
 
2
 
 and subcultured daily.
The unencapsulated variant of 
 
H. influenzae
 
 strain RD (obtained
from A. Reidl, Zentrum für Infektionsforschung) and 
 
M. catarrha-
lis
 
 strain 11994 (obtained from DSMZ) were grown on BHI agar
at 37
 
 
 
C, 5% CO
 
2
 
. For certain assays, bacteria were labeled with
 
0.2 
 
 
 
g/ml 5-(6)-carboxyfluorescein-succinylester (FITC; Molec-
ular Probes) in PBS for 15 min at 37
 
 
 
C in the dark and washed
three times with PBS before use.
 
Cell Culture.
 
The human embryonic kidney cell line 293T
(293 cells) was grown in DMEM/10% calf serum at 37
 
 
 
C, 5%
CO
 
2
 
. Cells were subcultured every 3–4 d. Prior to infection and
Rac pull-down assays, cells were serum starved overnight in
DMEM containing 0.5% calf serum. Primary human granulocytes
were purified from freshly drawn blood as described (17). Viabil-
ity of cells was determined before infection using trypan blue
staining and in all cases was 
 
 
 
90%.
 
Recombinant DNA Constructs.
 
Plasmids encoding cDNAs of
human CEACAM1, CEACAM3, CEACAM3 Y241F, and
CEACAM6 were provided by Wolfgang Zimmermann (Uni-
versitätsklinikum Grosshadern, München, Germany). CEACAM3
WT and CEACAM3 Y241F were amplified with primers
CEA3HA-sense, 5
 
 
 
-GGGAAGCTTGCCATGGGGCCCCCC-
TCAGCCTCTCCCCAC-3
 
 
 
 and CEA3HA-anti, 5
 
 
 
-GGGGAC-
GTCATAGGGATAAGAAGCCACTTCTGCTTTGTGGTC-
CATCCG-3
 
 
 
 and subcloned into the HindIII-AatII–digested
plasmid pBluescript FAK-HA (19) allowing an in-frame fusion of
the COOH-terminal cytoplasmic domain of CEACAM3 with
a double HA tag. CEACAM3 lacking the cytoplasmic domain
(CEACAM3 
 
 
 
CT) was constructed accordingly using primers
CEA3HA-sense and CEA3HA-deltaCTanti, 5
 
 
 
-GGGGACG-
TCATAGGGATATTTGGCAAGGAGCAGGAAACACACCA-
GTGC-3
 
 
 
. Introduction of the Y230F point mutation into
CEACAM3 WT and CEACAM3 Y241F was accomplished using
the Quikchange mutagenesis kit (Stratagene), resulting in
CEACAM3 Y230F and CEACAM3 Y230/241F. CEACAM3
constructs were verified by sequencing and subcloned via Hind-
III-NotI restriction sites into pcDNA3.1 (Invitrogen). Myc-
tagged Rac N17 and Cdc42 N17 were provided by Alan Hall
(University College, London, UK), VSV-tagged Rho N19 was
provided by Thomas Adam (Universitätsklinikum Charité, Ber-
lin, Germany), kinase-inactive c-Src (Src K297M) was provided
by David Schlaepfer (The Scripps Research Institute, La Jolla,
CA), and the GST-PAK CRIB domain (GST-CRIB) was pro-
vided by Gary Bokoch (The Scripps Research Institute, La Jolla,
CA). GST-CRIB was expressed in 
 
Escherichia coli
 
 BL-21 and pu-
rified using GSTrap FF (Amersham Biosciences). TAT-RacN17,
TAT Cdc42N17, and TAT-LacZ constructs were provided by
Steve Dowdy (University of California at San Diego, La Jolla,
CA), and the encoded proteins were expressed and purified as de-
scribed (20).
 
Reagents and Antibodies.
 
Phalloidin-TRITC was from Molec-
ular Probes. Rabbit antiserum against 
 
N. gonorrhoeae
 
 (AK92) was
provided by Thomas Meyer, and mAbs against the Opa proteins
(clone 4B12) were from Mark Achtman (Max-Planck-Institut für
Infektionsbiologie, Berlin, Germany), against the VSV epitope
(clone P5D4) were from Sigma-Aldrich, against the myc-epitope
(clone 9E10) were from Santa Cruz Biotechnology, against
Rac (clone 23A8) were from Upstate Biotechnology, and against
endoglin (clone P3D1) were from the Developmental Studies
Hybridoma Bank. mAb against the HA tag (clone 12CA5)
and against Src (clone 2–17) were purified from hybridoma
supernatants. mAb Kat4c recognizing CEACAM1, CEA, and
CEACAM6 was from DAKO, mAb COL-1 reacting with
CEACAM3 and CEA was purchased from Zymed Laboratories,
mAbs 26/3/13, specific for CEA, 9A6, specific for CEACAM6,
and D14HD11, crossreactive with all CEACAMs, were from
Genovac. Secondary antibodies were from Jackson ImmunoRe-
search Laboratories. Prior to phagocytosis inhibition experiments, 
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antibodies were cleared from sodium azide by 10 washes with
PBS using Vivaspin concentrators 50 K (Vivascience).
 
Electron Microscopy.
 
Phagocytes were seeded at 5 
 
 
 
 10
 
4
 
 cells/
well in 24-well plates on acid-washed glass coverslips and infected
with 10 bacteria per cell. After 1 h, infected cells were fixed with
2% glutaraldehyde in PBS for at least 1 h at 4
 
 
 
C and postfixed
with 1% osmium tetroxide in PBS for 1 h on ice. The samples
were dehydrated in a graded series of ethanol, critical point dried
from CO
 
2
 
, sputter coated with 8 nm gold-palladium, and exam-
ined at 25 kV accelerating voltage in a Hitachi S-800 field emis-
sion scanning electron microscope.
 
Transfection of Cells, Cell Lysis, and Western Blotting.
 
293 cells
were transfected by the standard calcium phosphate coprecipita-
tion method using 5 
 
 
 
g of CEACAM constructs or empty con-
trol vector. For cotransfection, 5 
 
 
 
g of cotransfected constructs
together with 3 
 
 
 
g of CEACAM constructs, respectively, were
used, and in all samples total DNA was adjusted to 8 
 
 
 
g using the
empty control vector. Cells were employed in infection experi-
ments 48 h after the transfection. Cell lysis and Western blotting
was performed as described (21).
 
Immunofluorescence Staining.
 
Immunofluorescence labeling
was performed as described (17). For differentiating between
extra- and intracellular bacteria, cells were infected with FITC-
labeled bacteria, and fixed samples were stained before perme-
abilization with polyclonal rabbit-anti–
 
N. gonorrhoeae
 
 and goat-
anti–rabbit-Cy5 in staining buffer (PBS, 5% FCS), resulting in
FITC-labeled intracellular and FITC/Cy5-labeled extracellular
bacteria. After permeabilization of the cells, phalloidin-TRITC
was used to stain cellular actin.
 
Gentamicin Protection Assay.
 
For gentamicin protection as-
says, 6 
 
 
 
 10
 
5
 
 293 cells in 24-well plates were infected with 20
bacteria/cell. After the infection, the medium was replaced with
DMEM containing 50 
 
 
 
g/ml gentamicin. After 45 min of incu-
bation, cells were lysed by the addition of 1% saponin in PBS for
20 min. Suitable dilutions were plated to determine the number
of recovered viable bacteria.
 
Determination of Rac-GTP Loading.
 
Rac-GTP loading in
transfected 293 cells was determined using a GST fusion protein
encompassing the CRIB domain of PAK (22). Briefly, cells were
lysed in Triton buffer (25 mM Hepes, pH 7.4, 1% Triton X-100,
150 mM NaCl, 20 mM MgCl
 
2
 
, 10% glycerol, 10 mM sodium
pyrophosphate, 100 mM NaF, 1 mM Na
 
3
 
VO
 
4
 
, and 10 
 
 
 
g/ml
each of aprotinin, leupeptin, pefabloc, and pepstatin), and cleared
lysates were incubated with 10 
 
 
 
g of GST-CRIB immobilized
on glutathione-agarose beads for 45 min at 4
 
 
 
C. After three
washes with Triton buffer, the precipitates were taken up in 2
 
 
 
SDS sample buffer and analyzed by Western blotting.
 
Granulocyte Phagocytosis.
 
Phagocytosis was determined by
FACS
 
®
 
 analysis according to Voyich et al. (23). Briefly, 10
 
6
 
 gran-
ulocytes were infected with 2 
 
 
 
 10
 
7
 
 FITC-labeled bacteria in 1
ml phagocytosis buffer (PB; 1
 
 
 
 PBS, 10 mM glucose, 1% heat
inactivated serum) for 15 min at 37
 
 
 
C. In inhibition experiments,
20 
 
 
 
g of the indicated, azide-free antibodies were added to the
cells 1 min before the infection. Phagocytosis was stopped by ad-
dition of ice-cold PB, samples were washed, taken up in cold
PBS, 2% FCS, 2 mg/ml Trypan blue, and analyzed on a FACS-
Calibur (Becton Dickinson). To obtain an estimate of the amount
of phagocytosed bacteria, the percentage of FITC-positive granu-
locytes was multiplied by the mean fluorescence of these cells.
For TAT-mediated protein transduction, granulocytes were in-
cubated for 1 h at 37
 
 
 
C with the indicated amounts of purified
TAT fusion proteins before infection and analyzed as above. In
control experiments, granulocytes were incubated with FITC-
labeled TAT-RacN17 and observed by confocal microscopy
to confirm the intracellular localization of the protein (Fig. S1
C, available at http://www.jem.org/cgi/content/full/jem.
20030204/DC1).
 
Phagocyte-mediated Bacterial Killing.
 
Assays were performed
according to Virji et al. (24). Briefly, 2 
 
 
 
 10
 
6
 
 bacteria were added
to 10
 
6
 
 PMN in 300 
 
 
 
l DMEM, 0.5% heat-inactivated FCS in
24-well plates. Before and after a 60-min incubation at 37
 
 
 
C, ali-
quots of the samples were collected and dilutions plated on GC
agar plates to determine the number of viable bacteria. In inhibi-
tion experiments, 20 
 
 
 
g of the indicated, azide-free antibodies
were added to the cells 1 min before the infection.
 
Online Supplemental Material.
 
Fig. S1 demonstrates (A) quench-
ing of the fluorescence emitted by FITC-labeled bacteria upon
Trypan blue addition; (B) Expression and purification of TAT-
Figure 1. OpaCEA-expressing
N. gonorrhoeae are efficiently rec-
ognized and eliminated by human
granulocytes via lamellipodia-like
membrane protrusions. (A) Gran-
ulocytes were incubated with
OpaCEA gonococci (Ngo OpaCEA)
or nonopaque, piliated gono-
cocci (Ngo Opa ), respectively.
At the indicated times, the number
of viable gonococci was deter-
mined and expressed as the per-
centage of the initial inoculum.
The graph shows mean values  
SDs of a representative experiment
done in triplicate. Equivalent
results were obtained with gran-
ulocytes isolated from four differ-
ent donors. (B–E) Pseudocolored
scanning electron micrographs of
granulocytes infected for 1 h
with OpaCEA gonococci (B and
C), nonopaque N. gonorrhoeae (D),
or nonpathogenic N. cinerea (E). 
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fusion proteins; and (C) TAT-mediated protein transduction of
human granulocytes. Fig. S2 shows (A) FACS
 
®
 
 analysis of
CEACAM expression on primary human granulocytes; (B) Oxi-
dative response of granulocytes upon infection with gonococci;
(C and D) CEACAM expression by transiently transfected 293
cells analyzed by Western blotting (C) or FACS
 
®
 
 (D), respec-
tively; and (E) adhesion of OpaCEA-expressing N. gonorrhoeae to
CEACAM-transfected 293 cells as observed by immunofluores-
cence microscopy. Figs. S1 and S2 are available at http://
www.jem.org/cgi/content/full/jem.20030204/DC1.
Results
Human Granulocytes Eliminate OpaCEA-expressing Gonococci.
Human granulocytes express three of the four CEACAM
family members, namely CEACAM1, CEACAM3, and
CEACAM6, that bind neisserial OpaCEA proteins (Fig. S2
A, available at http://www.jem.org/cgi/content/full/
jem.20030204/DC1). Accordingly, primary granulocytes
can efficiently recognize and eliminate OpaCEA N. gonor-
rhoeae in the absence of specific antibodies or complement
(4, 16). Indeed, when OpaCEA gonococci were incubated
with granulocytes at a 2:1 ratio, only  40% of the initial
bacterial inoculum could be recovered after 90 min (Fig.
1 A). Nonopaque organisms were not recognized or elim-
inated (Fig. 1 A). Contact of granulocytes with OpaCEA
N. gonorrhoeae  stimulated the cells to produce reactive ox-
ygen derivatives (Fig. S2 B) and to exhibit pronounced
lamellipodia-like protrusions on the surface (Fig. 1, B and
C). These membrane protrusions were involved in the
engulfment of the bacteria (Fig. 1 C). In contrast, non-
opaque gonococci only moderately stimulated the oxida-
tive burst of the granulocytes (Fig. S2 B), and neither
nonopaque gonococci nor nonpathogenic N. cinerea  in-
duced lamellipodia-like protrusions on the phagocyte sur-
face, indicating that the observed responses were due
to the OpaCEA–CEACAM interaction (Fig. 1, D and
E).  These results suggested that granulocytes express
CEACAM family member(s) with phagocytic properties.
This receptor(s) seems to transduce signals that stimulate
bactericidal mechanisms resulting in elimination of
CEACAM-binding bacteria. However, the identity of the
CEACAM family member(s) responsible for these pro-
cesses was unknown.
CEACAM3 and CEACAM6 Mediate Efficient Uptake of
OpaCEA-expressing Bacteria. To study the contribution of
specific CEACAM molecules to the internalization
of CEACAM-binding bacteria, we took advantage of 293
cells that do not express members of the CEACAM family
(Fig. S2, C and D; reference 25). Transfection of 293 cells
with CEACAM1, CEACAM3, CEACAM6, or the empty
control vector (pcDNA) resulted in the surface expression
of the respective receptor in  70–80% of the cell popula-
tion (Fig. S2 D). CEACAM-transfected cells supported
strong attachment of OpaCEA N. gonorrhoeae (Fig. S2 E). In
addition, CEACAM3 and CEACAM6 mediated internal-
ization of OpaCEA gonococci within 30–60 min after infec-
tion (Fig. 2 A). In contrast, internalization mediated by
CEACAM1 was  15% compared with CEACAM3, and
more than 100-fold lower numbers of bacteria were recov-
ered from control-transfected cells (pcDNA) (Fig. 2 A).
Importantly, the internalization process via CEACAM3
and CEACAM6 depended on the correct phenotype of the
bacteria, since nonopaque, piliated gonococci were barely
taken up by these receptors (Fig. 2 B). These results indi-
cated that both CEACAM3 and CEACAM6, but not
CEACAM1, are able to mediate efficient internalization of
OpaCEA gonococci when expressed in epithelial cells.
CEACAM3, but not CEACAM6, Is Connected to the
Small GTPase Rac. The opsonin-independent phagocy-
tosis of OpaCEA-expressing gonococci by human granulo-
cytes is accompanied by cytoskeletal rearrangements lead-
ing to lamellipodia formation and the production of
reactive oxygen metabolites (4, 11, 16), processes that are
regulated by the small GTPase Rac (26). To analyze if
CEACAM3- or CEACAM6-mediated phagocytosis might
be connected to small GTPases of the Rho family, 293 cells
were cotransfected with CEACAMs and with constructs
encoding dominant-negative versions of Cdc42, Rac, and
RhoA. Importantly, a strong decrease in CEACAM3-
mediated uptake of opaque gonococci was observed upon
coexpression of dominant-negative Rac (Rac N17; Fig. 3 A).
In contrast, bacterial internalization via CEACAM6 was
Figure 2. Transient expression of
CEACAMs in 293 cells allows interaction
with OpaCEA gonococci. (A) 293 cells were
transfected with CEACAM1, CEACAM3,
CEACAM6, or the empty expression vector
(pcDNA). After 2 d, cells were infected
with OpaCEA gonococci. At the indicated
time points, the number of internalized
bacteria was determined by gentamicin pro-
tection assays. The graph shows mean values  
SDs of three independent experiments done
in triplicate. (B) Transfected 293 cells were
infected with nonopaque (Opa ), non-
opaque, piliated (Opa /P ), or OpaCEA-
expressing (OpaCEA) gonococci for 1 h and
analyzed in gentamicin protection assays.
The graph shows mean values   SDs of two
independent experiments done in triplicate.Schmitter et al. 39
only marginally diminished by Rac N17, suggesting that
CEACAM3 might be the granulocyte receptor that is con-
nected to the small GTPase Rac. Interestingly, neither
CEACAM3- nor CEACAM6-mediated internalization
was compromised by coexpression of dominant-negative
versions of the closely related small GTPases Cdc42hs
(Fig. 3 A) or RhoA (unpublished data).
To investigate further if CEACAM3 is connected to
Rac after N. gonorrhoeae infection, cells infected for 30 min
were stained for gonococci and Rac. Importantly, cells
transfected with CEACAM3 showed recruitment of Rac
to the vicinity of attached OpaCEA bacteria (Fig. 3 B). In
contrast, the distribution of Rac did not change in cells
transfected with CEACAM6, despite the attachment of
multiple gonococci (Fig. 3 B).
Biochemically, Rac stimulation is reflected by its GTP-
loading status. Upon infection with OpaCEA gonococci, we
observed a strong increase in GTP-Rac in CEACAM3-
expressing 293 cells compared with uninfected cells (Fig. 4
A, top). This increase was already detectable 15 min after
infection and reached maximum levels between 30 and 60
min paralleling the kinetics of efficient, CEACAM3-medi-
ated internalization. In contrast, no increase in GTP-
Rac  was observed in control vector-transfected or in
CEACAM6-expressing cells after infection (Fig. 4 A, top).
An increase in Rac-GTP–loading was only detected in re-
sponse to OpaCEA-expressing bacteria but not upon infec-
tion with nonopaque gonococci or nonpathogenic N. ci-
nerea (Fig. 4 B), demonstrating that it is the specific
interaction between the bacterial OpaCEA adhesin and host
CEACAM3 that mediates stimulation of Rac. Importantly,
the levels of Rac-GTP induced by the different bacterial
strains paralleled the internalization of these bacteria via
CEACAM3 (Fig. 4 C). Together, these data corroborate
the view that CEACAMs might be differentially connected
to intracellular signaling pathways and that in particular
CEACAM3 might be responsible for the stimulation of the
small GTPase Rac in response to OpaCEA gonococci.
The ITAM-like Sequence in the Cytoplasmic Domain of
CEACAM3 Is Required for OpaCEA-mediated Uptake and Rac
Stimulation. Since the possession of the cytoplasmic do-
main is a distinctive feature of CEACAM3 that is absent
from GPI-anchored CEACAM6, we wondered whether
residues in the cytoplasmic domain of CEACAM3 are re-
sponsible for the internalization and/or for the observed
stimulation of Rac. Therefore, a panel of CEACAM3 mu-
tants were generated containing a deletion of the cytoplas-
mic domain ( CT) or point mutations disrupting the
ITAM-like sequence (Fig. 5 A) by substitutions of tyrosine
for phenylalanine at either one or both positions (Y230F,
Y241F, Y230/241F). In addition, a COOH-terminal HA
tag was introduced. When 293 cells were transiently trans-
fected with the respective constructs, equivalent levels of
the proteins were expressed (Fig. 5 B). Importantly, uptake
Figure 3. CEACAM3- but
not CEACAM6-mediated inter-
nalization of gonococci depends
on the small GTPase Rac. (A) 293
cells cotransfected with Cdc42
N17 or Rac N17 and either
CEACAM3 or CEACAM6 were
infected with OpaCEA gonococci,
and the number of internalized
bacteria was determined in gent-
amicin protection assays. The
graph shows mean values   SDs
of three independent experiments
done in triplicate. Western blot-
ting of whole cell lysates (WCL)
with anti–myc tag antibody dem-
onstrates expression of transfected
Cdc42 N17 and Rac N17, respec-
tively.  (B) 293 cells, transfected
with CEACAM3 or CEACAM6,
were infected with OpaCEA  N.
gonorrhoeae for 1 h, fixed, and
stained with polyclonal antibodies
against gonococci and mono-
clonal antibodies against Rac. In
CEACAM3-transfected cells, Rac
is recruited to the site of bacteria–
cell interaction (arrowhead).Granulocyte CEACAM3 Mediates Phagocytosis of Human-specific Pathogens 40
mediated by HA-tagged WT CEACAM3 was comparable
to the internalization observed before with the untagged
receptor, demonstrating that the addition of the HA tag did
not alter the functionality of the protein (Fig. 5 C). How-
ever, deletion of the cytoplasmic domain of CEACAM3
( CT) led to almost complete abolishment of internaliza-
tion of OpaCEA gonococci (Fig. 5 C). The ITAM-like se-
quence of CEACAM3 seemed to play a critical role, since
substitution of either Y230 or Y241 resulted in  30% re-
duction in bacterial uptake. Simultaneous mutation of both
tyrosine residues resulted in a  60% reduction of internal-
ization (Fig. 5 C). Nevertheless, uptake mediated by
CEACAM3 Y230/241F was consistently higher than in-
ternalization via CEACAM3  CT, suggesting that addi-
tional residues within the cytoplasmic domain aside from
the ITAM-like sequence can contribute to a low level of
uptake. To analyze if the cytoplasmic domain is required
for stimulation of Rac, pull-down analyses were per-
formed. As observed before, infection of CEACAM3-
expressing 293 cells with opaque gonococci resulted in
enhanced GTP-loading of Rac (Fig. 5 D). In contrast,
pcDNA, CEACAM3  CT, or CEACAM3 Y230/241F-
transfected cells did not respond to the bacterial challenge
(Fig. 5 D) supporting the view that the ITAM-like se-
quence in the cytoplasmic domain of CEACAM3 links re-
ceptor engagement with enhanced GTP-loading of Rac.
Src Kinase Activity Is Critical for CEACAM3-mediated
Uptake and Rac Stimulation. Purified c-Src phosphorylates
the CEACAM3 cytoplasmic domain in vitro (27), and Src
PTKs are activated and phosphorylate CEACAM3 in gran-
ulocytes in response to opaque gonococci (17, 28). To ana-
lyze if Src PTKs play a role in CEACAM3-mediated bacte-
rial internalization and Rac stimulation, a kinase-inactive
Figure 4. CEACAM3 engagement by OpaCEA gonococci results in
Rac stimulation. (A) 293 cells transfected with the indicated constructs
were infected with OpaCEA N. gonorrhoeae for different time points. GTP-
bound Rac was isolated using the Rac-binding domain of PAK (GST-
CRIB) and detected by Western blotting with anti-Rac antibodies (top).
Whole cell lysates (WCL) were also probed with anti-Rac antibodies
(bottom). (B) CEACAM3-expressing 293 cells were left uninfected or
were infected with N. cinerea, piliated, nonopaque N. gonorrhoeae (Ngo
Opa ) or OpaCEA N. gonorrhoeae (Ngo OpaCEA). GST-CRIB pull-downs
(top) or whole cell lysates (middle) were probed with anti-Rac antibodies.
Lysates of the bacteria were probed with monoclonal anti-Opa antibody
(bottom). (C) 293 cells transfected with the empty control vector
(pcDNA) or CEACAM3 were infected with the bacteria employed in B
and analyzed in gentamicin protection assays. The graph shows mean val-
ues   SDs of three independent experiments done in triplicate.
Figure 5. The ITAM-like sequence of CEACAM3 is critical for bacterial
internalization and Rac stimulation. (A) Primary sequence of the
COOH-terminal cytoplasmic domain of CEACAM3 containing the
ITAM-like sequence. The ITAM consensus (31) is shown below with
the critical tyrosine residues in bold. (B) 293 cells were transfected with
the control vector (pcDNA) or the indicated HA-tagged CEACAM3
constructs. Whole cell lysates (WCL) were analyzed with anti–HA tag
antibody. (C) Transfected cells as in B were infected with OpaCEA-expressing
gonococci for 60 min and analyzed in gentamicin protection assays. The
graph shows mean values   SDs of three to four independent experiments
done in triplicate. (D) Cells were transfected as in B, and samples were
lysed before or after 60 min of infection with OpaCEA N. gonorrhoeae.
GST-CRIB pull-down assays (top) or whole cell lysates (WCL; bottom)
of the samples were analyzed with monoclonal anti-Rac antibody.Schmitter et al. 41
version of c-Src (Src K297M) was overexpressed in 293
cells. Notably, cells coexpressing CEACAM3 and Src
K297M showed a prominent decrease in uptake of OpaCEA
N. gonorrhoeae (Fig. 6 A). To investigate if Src PTK activity
is upstream of Rac stimulation by CEACAM3, lysates were
analyzed by pull-down assays with the GST-CRIB do-
main. Again, CEACAM3-transfected cells showed an in-
crease in GTP-Rac upon infection with OpaCEA pathogens
(Fig. 6 B). However, in cells coexpressing CEACAM3 and
Src K297M the increase in GTP-Rac was completely sup-
pressed (Fig. 6 B). Together, these results suggest that
CEACAM3-mediated stimulation of the small GTPase
Rac depends on Src kinase–initiated signaling via the
CEACAM3 cytoplasmic domain ITAM-like sequence.
Inhibition of CEACAM3 Blocks Efficient Phagocytosis of
OpaCEA Gonococci by Human Granulocytes. To address the
functional significance of CEACAM3-initiated processes in
human granulocytes, we analyzed the opsonin-indepen-
dent phagocytosis of bacteria by primary granulocytes.
Therefore, phagocytes were incubated with FITC-labeled
bacteria, and internalization of bacteria was determined by
FACS® analysis after quenching with trypan blue (23).
Control experiments showed that addition of trypan blue
reduced the fluorescence of extracellular bacteria by  90%
(Fig. S1 A). As expected, nonopaque gonococci were only
poorly phagocytosed (depending on the donor, 5–10% of
the granulocyte population were FITC positive) and
yielded a signal of intracellular fluorescence comparable to
uninfected cells, whereas granulocytes readily internalized
OpaCEA-expressing bacteria (75–95% of the granulocyte
population) (Fig. 7 A). However, in the presence of the
CEACAM3-specific monoclonal antibody a decreased
phagocytosis of OpaCEA gonococci was observed, whereas
addition of an isotype-matched control antibody against
endoglin or addition of a CEACAM6-recognizing anti-
body only marginally interfered with internalization (Fig. 7
B). PP2, a specific pharmacological inhibitor of Src family
PTKs, blocked the uptake of OpaCEA gonococci to the
same extent as CEACAM3-specific antibodies (Fig. 7 B).
This observation is in agreement with the view that
CEACAM3-mediated phagocytosis requires Src PTK ac-
tivity. The reduced fluorescence signal from intracellular
bacteria in the presence of the CEACAM3-specific anti-
bodies was indeed due to decreased internalization of bac-
teria, as shown by differential staining of intra- and extra-
cellular bacteria in infected samples (Fig. 7 C). In the
absence of antibodies or in the presence of a CEACAM6-
specific antibody, numerous OpaCEA-expressing N. gonor-
rhoeae were located inside the primary granulocytes. How-
ever, a marked reduction of intracellular bacteria could be
observed in the presence of the CEACAM3-specific anti-
body (Fig. 7 C), suggesting that CEACAM3 is the pre-
dominant CEACAM family member responsible for the
opsonin-independent uptake of CEACAM-binding gono-
cocci by human granulocytes.
Interference with CEACAM3 or Rac Stimulation Decreases
Phagocytosis and Killing of OpaCEA-expressing Gonococci by
Granulocytes. If CEACAM3 is the major CEACAM fam-
ily member contributing to the uptake of OpaCEA gono-
cocci, then interference with Rac stimulation should also
affect the internalization of the bacteria. Therefore, granu-
locytes were pretreated with a purified TAT fusion of
dominant-negative Rac (TAT-RacN17),  -galactosidase
(TAT-LacZ), or dominant-negative Cdc42 (TAT-
Cdc42N17) (Fig. S1 B) and then incubated with FITC-
labeled gonococci. Importantly, TAT-RacN17 severely di-
minished the opsonin-independent phagocytosis of OpaCEA
N. gonorrhoeae by human granulocytes in a dose-dependent
manner, whereas neither TAT-LacZ nor TAT-Cdc42N17
interfered with this process (Fig. 8 A). These results further
support the hypothesis that CEACAM3 is the major granu-
locyte receptor of the CEACAM family mediating uptake
of OpaCEA gonococci.
To investigate if the efficient CEACAM3-mediated
phagocytosis finally leads to the killing and elimination of
the microorganisms, primary human granulocytes were in-
cubated with OpaCEA gonococci, and the amount of viable
bacteria was determined after 60 min of coincubation. As
observed before,  60% of the inoculated OpaCEA-express-
ing, but not nonopaque gonococci, were eliminated by the
phagocytes within 60 min (Fig. 8 B). However, when the
CEACAM3-specific antibody was added before infection
an improved survival of OpaCEA gonococci could be ob-
served, whereas addition of the isotype-matched control
antibody or a CEACAM6-recognizing antibody only mar-
ginally altered the survival of the bacteria (Fig. 8 B). To-
Figure 6. Src kinases connect CEACAM3 engage-
ment with Rac stimulation. (A) 293 cells were trans-
fected with the control vector (pcDNA), CEACAM3,
or cotransfected with a kinase-inactive mutant of c-Src
(c-Src K297M), infected with OpaCEA gonococci, and
employed in gentamicin protection assays. The graph
shows mean values   SDs of two independent experi-
ments done in triplicate. Whole cell lysates (WCL) of
the samples were analyzed for Src expression (bottom).
(B) Lysates of cells as in A were prepared before and after
infection with OpaCEA gonococci. GST-CRIB pull-
down assays (top) or whole cell lysates (WCL; bottom)
of the samples were analyzed with monoclonal anti-
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gether, these results suggest that CEACAM3-mediated Rac
stimulation is a major pathway leading to the opsonin-
independent uptake and elimination of CEACAM-binding
gonococci by human granulocytes.
CEACAM3 Mediates Rac Stimulation and Phagocytosis in
Response to H. influenzae and M. catarrhalis. To address if
CEACAM3 plays a significant role in the elimination and
control of other CEACAM-binding pathogens, we inves-
Figure 7. CEACAM3 is criti-
cal for uptake of CEACAM-
binding bacteria by primary
human granulocytes. (A) Granu-
locytes were incubated with
FITC-labeled OpaCEA gonococci
(Ngo OpaCEA) or nonopaque,
piliated gonococci (Ngo Opa ),
respectively, or left uninfected.
After 20 min, phagocytosis was
measured by FACS® analysis.
Values represent the percentage
of granulocytes containing
FITC-labeled bacteria from a
representative experiment. Similar
values were obtained with gran-
ulocytes from three different
donors. (B) Phagocytosis of
OpaCEA bacteria was analyzed as
above in the absence or presence
of 20  g of the indicated mono-
clonal antibodies or 10  M of
the Src PTK inhibitor PP2. The
graph shows mean values of a
representative experiment done
in triplicate. Equivalent results
were obtained with granulocytes
isolated from three different
donors. (C) Human granulocytes
were infected with FITC-labeled
OpaCEA gonococci in the presence
or absence of 20  g of the indi-
cated monoclonal antibodies for
60 min. Cells were differentially
stained for extracellular (arrow-
heads) and intracellular bacteria
(small arrow). Cellular actin
was  visualized with phalloidin-
TRITC.Schmitter et al. 43
tigated if M. catarrhalis or H. influenzae are recognized by
CEACAM3 and if they trigger Rac-GTP loading. Indeed,
in CEACAM3-expressing 293 cells a nonencapsulated
variant of H. influenzae strain RD stimulated a strong in-
crease in Rac-GTP upon infection, whereas no such in-
crease was observed in cells transfected with the empty
control vector (Fig. 9 A). Again, Rac-GTP loading in re-
sponse to H. influenzae was correlated with enhanced
CEACAM3-mediated internalization of these pathogens,
albeit at lower levels than observed in response to OpaCEA
gonococci (Fig. 9 B). Moreover, a UspA1-positive M. ca-
tarrhalis strain enhanced Rac-GTP loading and was inter-
nalized by 293 cells in a CEACAM3-dependent manner
(Fig. 9, C and D). Interference with CEACAM3, and to a
lesser extent with CEACAM6, on primary human granu-
locytes decreased phagocytosis of H. influenzae, and uptake
of M. catarrhalis was strongly diminished by CEACAM3-
specific antibodies (Fig. 9 E), suggesting that CEACAM3
is involved in clearance of diverse microorganisms that tar-
get human CEACAMs. Together, these data support the
view that CEACAM3 is a major granulocyte receptor re-
sponsible for Rac stimulation by an opsonin-independent
phagocytosis of diverse CEACAM-binding, human-spe-
cific pathogens.
Discussion
The human pathogens N. gonorrhoeae, N. meningitidis, M.
catarrhalis, and H. influenzae avoid acquired immune defenses
of their host by sophisticated mechanisms such as variation
of surface structures or secretion of IgA-specific proteases.
However, despite widespread colonization with some of these
Figure 8. CEACAM3 and Rac stimulation are required for efficient
uptake and elimination of OpaCEA gonococci by primary human gran-
ulocytes. (A) Granulocytes were either untreated or pretreated with
the indicated amounts of TAT-LacZ, TAT-RacN17, or TAT-
Cdc42N17 and infected with FITC-labeled OpaCEA gonococci (Ngo
OpaCEA). Phagocytosis was determined by FACS® analysis, and the
graphs show the result of a representative experiment. Similar results
were obtained with granulocytes isolated from three different donors.
(B) Granulocytes were incubated with OpaCEA gonococci (Ngo OpaCEA)
or nonopaque, piliated gonococci (Ngo Opa ), respectively, in the
absence or presence of 20  g of the indicated antibodies. Before and
after 60 min of incubation, aliquots of the samples were plated on GC
agar to determine the number of viable gonococci. The graph shows
mean values   SDs of a representative experiment done in triplicate.
Equivalent results were obtained with granulocytes isolated from
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microorganisms, severe disease outcomes occur only in a
small portion of the host population, suggesting that innate
immune defenses are able to contain the bacteria in most cases.
We demonstrate here that human granulocytes not only rec-
ognize CEACAM-binding variants of these pathogens but that
bacterial engagement of a granulocyte-specific member of the
CEACAM family, CEACAM3, initiates phagocyte effector
mechanisms leading to the elimination of the microbes.
It has been observed previously that human granulocytes
can recognize opaque variants of pathogenic Neisseriae in an
opsonin-independent manner (29) and that this recognition
depends on members of the CEACAM family (4, 5, 17).
Overexpression of individual CEACAM family members
in nonphagocytic cells has revealed that several CEACAMs
can mediate uptake in such a cellular background (11, 12,
18). However, the role of individual receptors in the inter-
action of granulocytes with CEACAM-binding pathogens
has not been analyzed. The data presented in this study
provide for the first time biochemical and functional evi-
dence that CEACAM3 is the predominant CEACAM fam-
ily member on human granulocytes mediating elimination
of CEACAM-binding bacteria. Since there is no endoge-
nous ligand known for CEACAM3 (13), the recognition of
pathogenic  Haemophilus,  Moraxella, and Neisseria species
now assigns a function to this orphan receptor of the innate
immune system.
The efficient CEACAM3-mediated clearance of bacterial
pathogens seems to be closely linked to the ability of this re-
ceptor to stimulate the small GTPase Rac, a critical regula-
tor of actin polymerization, phagocytosis, and the oxidative
response of granulocytes (30). Though CEACAM6 can me-
diate internalization when overexpressed in epithelial cell
lines (11, 12), bacterial engagement of CEACAM6 did not
lead to Rac stimulation, and interference with CEACAM6
did not block the clearance of CEACAM-binding bac-
teria by human granulocytes. The difference between
CEACAM3- and CEACAM6-mediated events is due to
the presence of an ITAM-like sequence in the CEACAM3
cytoplasmic tail. ITAMs have been characterized in several
receptors belonging to the Ig superfamily (31). ITAM func-
tion depends on the phosphorylation of key tyrosine resi-
dues that is often mediated by Src family protein tyrosine
kinases (32). Interestingly, tyrosine residue Y241 within the
CEACAM3 ITAM-like sequence is embedded in the con-
text of YxxM, where a methionine residue is located at the
 3 position with respect to the tyrosine (compared with
YxxL/I in the canonical ITAM [31]). Such a YxxM se-
quence has been shown to serve as a preferred docking site
for SH2 domains of the p85 subunit of phosphatidylinositol
3 -kinase (PI-3K) (33). Therefore, we would predict
that  phosphorylated Y241 connects phosphorylation of
CEACAM3 to the reported recruitment of PI-3K (34).
Since the products of PI-3K can activate several Rac GEFs,
such as Vav and SWAP70 (35, 36), PI-3K binding is a po-
tential molecular link between CEACAM3 ITAM phos-
phorylation and downstream Rac stimulation.
CEACAM3 does not engage in homo- or heterotypic
interactions with other CEACAM family members, and
endogenous ligands are unknown (37). In light of the re-
sults presented in this paper, CEACAM3 is best viewed as a
specifically adapted single chain phagocytic receptor in-
volved in the clearance of CEACAM-binding bacteria by
human granulocytes. Most of the known CEACAM-bind-
ing bacterial species are human-specific pathogens. Like-
wise, the expression of CEACAM3 is also restricted to hu-
man granulocytes, and no homologues of CEACAM3 have
been detected in rodents or nonhuman primates (38, 39),
suggesting a striking coevolution of human innate immune
defenses with a restricted set of specialized pathogens. It is
tempting to speculate that gonorrhea-associated complica-
Figure 9. M. catarrhalis and H. influenzae are recognized and phagocytosed
via CEACAM3. (A) Empty control vector (pcDNA) or CEACAM3-
transfected 293 cells were left uninfected or were infected with unencap-
sulated H. influenzae strain RD for 60 min. GST-CRIB pull-downs (top)
or whole cell lysates (bottom) were probed with anti-Rac antibodies.
(B) Cells as in A were infected with H. influenzae strain RD and analyzed
in gentamicin protection assays. The graph shows mean values   SDs of
two independent experiments done in triplicate. (C) CEACAM3-transfected
293 cells were left uninfected or were infected with M. catarrhalis strain
11994 or with OpaCEA gonococci (Ngo OpaCEA) for 60 min. GST-CRIB
pull-downs (top) or whole cell lysates (bottom) were probed with anti-
Rac antibodies. (D) 293 cells transfected with the empty control vector
(pcDNA) or CEACAM3 were infected with M. catarrhalis for 60 min and
analyzed in gentamicin protection assays. The graph shows mean val-
ues   SDs of two independent experiments done in triplicate. (E) Hu-
man granulocytes were infected with FITC-labeled M. catarrhalis or H. influ-
enzae, respectively, in the presence or absence of the indicated antibodies
for 20 min and analyzed by FACS® for intracellular bacteria. The graphs
show the results of representative experiments. Similar results were ob-
tained with granulocytes isolated from two different donors.Schmitter et al. 45
tions effecting reproduction such as early trimester abortion
or infertility (40) might have provided a selective advantage
to individuals able to counteract CEACAM-binding bacte-
ria by innate immune defenses. On the other hand, patho-
gens might evolve variants of their CEACAM-binding ad-
hesins that retain association with CEACAM family
members expressed on epithelial cells (such as CEA or
CEACAM1) but that loose recognition by CEACAM3.
Such adhesins would allow attachment to and invasion of
epithelial cells but would avoid elimination by granulo-
cytes. Indeed, several meningococcal and gonococcal
OpaCEA proteins have been characterized that exhibit this
property (11, 12, 41, 42). It will be interesting to investi-
gate whether the ability to cause severe forms of disease is
correlated with the expression of CEACAM-binding ad-
hesins that are not recognized by CEACAM3.
Together, the results presented in this paper describe the
orphan receptor CEACAM3 as a novel single-chain
phagocytic receptor of the innate immune system. Since
internalization via CEACAM3 is opsonin independent, this
receptor should be of particular importance in the control
of bacteria that do not induce protective acquired immune
responses. Since multiple commensal and pathogenic bac-
teria found in association with human mucosal surfaces
are exploiting CEACAM family members (43–45),
CEACAM3-mediated, opsonin-independent phagocytosis
by granulocytes might be a general defense mechanism
evolved by the human innate immune system directed
against CEACAM-binding microorganisms.
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